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Immunohistochemistry of thymus samples using anti-human CD23 
antibody and HRP conjugated secondary. A) Grade 0 sample with no 
GC B) Grade 4 sample with several GCs. 
Fig.2 Gradation of thymus samples
CONCLUSIONS:
❖ Grade 0 and grade 1-4 patients have distinct mRNA and miRNA 
profile demonstrating separation of groups.  
❖ Deregulation of 100 annotated mRNA and 34 mature miRNA.
❖ Reciprocal expression pairing of miRNA and mRNA observed.
❖ Maintenance of autoimmunity is supported by regulatory 
pathways known to be involved in neoplasia
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BACKGROUND: Myasthenia gravis (MG) is an autoimmune 
neuromuscular disorder caused by antibodies directed against 
proteins present at the post-synaptic surface of neuromuscular 
junction (NMJ). A characteristic pathology of patients with early 
onset MG is thymic hyperplasia with ectopic germinal centers 
(GC). However, mechanisms that trigger and maintain thymic 
hyperplasia are poorly characterized. Micro-RNAs (miRNA) are 
small, non-coding RNAs that are increasingly appreciated to be 
involved in the pathology of several autoimmune diseases. In 
order to determine the central mechanisms involved in the 
pathology, thymus samples from MG patients were assessed 
by histology and grouped based on appearance of GC 
compared to samples without them. MiRNA and mRNA profiles 
were evaluated. 
Fig.1 Germinal center activity in MG thymus
Adapted from B. A. Heesters et. al., 2014,  Nature Reviews Immunology
METHODS: Thymic specimens collected during the course of 
the NIH-supported study of thymectomy (MGTX, U01 NS4268) 
were used for histological analysis to grade the degree of 
thymic hyperplasia, grade 0, no observed GC and grade 1 to 4 
with varying numbers of GCs. MiRNA and mRNA were 
evaluated using GeneChip® miRNA 4.0 Array and GeneChip® 
Human Transcriptome Array 2.0, respectively.  Partek Genomic 
Suite 6.6 and Transcriptome Analysis Console 2.0 programs 
were used to identify candidates that were differentially 
expressed in grade 0 versus grades 1 to 4. ANOVA p-value <0.
05 and FDR<0.05 was determined as significant. Further 
validation by qRT-PCR was done. Ingenuity Pathway Analysis 
was used to identify miRNA targets, pathways involved and 
reciprocal expression pairing of miRNA-mRNA. IHC was 
performed to check localization of proteins. 
Fig.3 Differential mRNA expression in MG thymus
A) Hierarchical Clustering of significant genes in grade 0 vs. 1-4 (p<0.
05, no fold change). B) Cellular and molecular functions associated.
Fig.4 Cluster analysis of small RNA expression 
profile stratifying samples across the grades 
Differentially expressed small RNAs showing greater than 1.5 fold 
change in expression between the grades. ANOVA p<0.05
Fig.6 mRNA and miRNA regulating cellular functions
 in germinal center formation
Fig.5 Reciprocal Pairing of miRNA and mRNA
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Ingenuity Pathway Analysis predicted 7 miRNA-mRNA pairs that were validated 
by qPCR. Increase in RGS13 (A) accompanied by decrease in miR 139-5p (B) 
and miR 452-5p (C) in grades 1-4. Immunohistochemistry of thymus samples 
using RGS13 antibody confirms its expression in GC. H and E staining 4x (D) anti 
RGS13-HRP 4x (E) and at 60X (F). 
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